| Literature DB >> 22533538 |
Melanie Calvert1, Helen Duffy, Nick Freemantle, Russell Davis, Gregory Y H Lip, Paramjit Gill.
Abstract
BACKGROUND: Population health status scores are routinely used to inform economic evaluation and evaluate the impact of disease and/or treatment on health. It is unclear whether the health status in black and minority ethnic groups are comparable to these population health status data. The aim of this study was to evaluate health-status in South Asian and African-Caribbean populations.Entities:
Mesh:
Year: 2012 PMID: 22533538 PMCID: PMC3349523 DOI: 10.1186/1472-6963-12-101
Source DB: PubMed Journal: BMC Health Serv Res ISSN: 1472-6963 Impact factor: 2.655
Patient Demographics
| South Asian | South Asian where EQ-5D score = 1 | African-Caribbean | African-Caribbean where EQ-5D score = 1 | |
|---|---|---|---|---|
| n | 3442 | 2402 | 1912 | 1447 |
| Age (mean [SD], years) | 59.7 (10.4) | 58.2 (9.7) | 62.7 (12.0) | 61.1 (11.6) |
| Female, n (%) | 1752 (50.90%) | 1103 (45.92) | 1058 (55.33%) | 766 (52.94) |
| Systolic blood pressure (Mean, SD, mm Hg) | 139.51 (19.85) | 139.39 (19.84) | 144.32 (19.88) | 144.01 (19.50) |
| Diastolic blood pressure (Mean, SD, mm Hg) | 80.87 (10.91) | 81.46 (10.83) | 81.99 (10.79) | 82.54 (10.61) |
| Ever smoked, n (%) | 801 (23.27) | 572 (23.81) | 826 (43.20) | 624 (43.12) |
| Consumes alcohol (occasionally or regularly), n (%) | 552 (16.04) | 456 (18.98) | 1306 (68.31) | 1015 (70.15) |
| BMI Median (IQR) | 27.56 (24.89 to 31.13) | 27.27 (24.78 | 28.99 (25.89 | 28.56 (25.57 to 32.36) |
| Index of Multiple Deprivation 2007 Median, IQR [ | 54.74(39.02 | 54.85 (39.29 to 61.50) | 57.93(46.25 to 61.34) | 57.93 (46.25 |
| Born in the UK, n (%) | 55 (1.60) | 47 (1.96) | 309 (16.16) | 266 (18.38) |
| Interviewed in English, n (%) | 1508 (43.81) | 1129 (47.0) | 1904 (99.58) | 1443 (99.72) |
| Angina | 328 (9.53) | 194 (8.08) | 87 (4.55) | 47 (3.25) |
| Arrhythmias | 58 (1.69) | 31 (1.29) | 46 (2.41) | 18 (1.24) |
| Arthritis | 1345 (39.08) | 717 (29.85) | 813 (42.52) | 516 (36.57) |
| Asthma | 414 (12.03) | 254 (10.57) | 199 (10.41) | 136 (9.40) |
| Cancer | 64 (1.86) | 39 (1.62) | 86 (4.50) | 51 (3.52) |
| COPD | 35 (1.02) | 18 (0.75) | 29 (1.52) | 17 (1.17) |
| Depression | 277 (8.05) | 64 (2.66) | 89 (4.65) | 30 (2.07) |
| Diabetes | 1060 (30.80) | 693 (28.85) | 503 (26.31) | 337 (23.29) |
| Heart Failure | 46 (1.34) | 16 (0.67) | 29 (1.52) | 12 (0.83) |
| Hypertension | 1570 (45.61) | 987 (41.09) | 1106 (57.85) | 776 (53.63) |
| Myocardial ischemia | 299 (8.69) | 188 (7.83) | 64 (3.35) | 35 (2.42) |
| Peripheral artery disease | 18 (0.52) | 6 (0.25) | 26 (1.36) | 11 (0.76) |
| Stroke/TIA | 157 (4.56) | 65 (2.71) | 67 (3.50) | 24 (1.66) |
| Number of medical conditions (Median, IQR) | 1 (1 to 3) | 1 (0 to 2) | 2 (1 to 2) | 1 (1 to 2) |
| ACE Inhibitors | 818 (23.77) | 524 (21.82) | 465(24.32) | 316 (21.84) |
| Diuretics | 639 (18.56) | 384 (15.99) | 616 (32.22) | 418 (28.89) |
| Beta-blockers | 470 (13.65) | 294 (12.24) | 236 (12.4) | 150 (10.37) |
| Calcium Antagonists | 613 (17.81) | 364 (15.15) | 716 (37.45) | 498 (34.42) |
| Aspirin | 1054 (30.62) | 691 (28.77) | 563 (29.45) | 380 (26.26) |
| Warfarin | 35 (1.02) | 19 (0.79) | 34 (1.78) | 15 (1.04) |
| Digoxin | 13 (0.38) | 4 (0.17) | 13 (0.68) | 3 (0.21) |
| Lipid regulating drugs | 1483 (43.09) | 969 (40.34) | 731 (38.23) | 520 (35.94) |
Numbers (percentages) of South Asian (SA) and African-Caribbean (AC) respondents, reporting any problem (moderate or severe) for each EQ-5D dimensions by age group
| Number (%) of respondent reporting any problem (by age group) | |||||
|---|---|---|---|---|---|
| Age group, years | 40-49 | 50-59 | 60-69 | 70-79 | ≥ 80 |
| SA | 16 | 90 | 104 | 129 | 56 |
| AC | 14 | 19 | 44 | 92 | 50 |
| SA | 11 | 50 | 66 | 97 | 46 |
| AC | 11 | 15 | 35 | 76 | 41 |
| SA | 22 | 87 | 102 | 150 | 54 |
| AC | 12 | 20 | 52 | 103 | 54 |
| SA | 76 | 226 | 160 | 153 | 43 |
| AC | 26 | 40 | 61 | 117 | 42 |
| SA | 85 | 162 | 71 | 48 | 10 |
| AC | 30 | 38 | 36 | 52 | 12 |
Figure 1Mean EQ-5D scores from a sample of the UK general population, assessed in 1993, by age, [8]compared to mean scores from South Asian and African-Caribbean participants in the E-ECHOES study (95% CI are indicated).
Multivariable model results showing the change in EQ-5D score associated with each explanatory variable
| Effect | Estimate | Lower 95% CI | Upper 95% CI | P Value |
|---|---|---|---|---|
| 0.267 | 0.097 | 0.436 | 0.004 | |
| -0.003 | -0.003 | -0.002 | < .0001 | |
| -0.021 | -0.030 | -0.012 | < .0001 | |
| -0.002 | -0.003 | -0.001 | < .0001 | |
| Angina | 0.039 | 0.018 | 0.059 | 0.0002 |
| Arrythmia | 0.075 | 0.042 | 0.107 | < .0001 |
| Arthritis | 0.091 | 0.076 | 0.107 | < .0001 |
| Asthma | 0.049 | 0.032 | 0.067 | < .0001 |
| Cancer | 0.046 | 0.017 | 0.074 | 0.0016 |
| COPD | 0.060 | 0.019 | 0.101 | 0.004 |
| Depression | 0.166 | 0.146 | 0.187 | < .0001 |
| Diabetes | 0.029 | 0.015 | 0.044 | 0.0001 |
| Heart Failure | 0.110 | 0.072 | 0.147 | < .0001 |
| Hypertension | 0.039 | 0.021 | 0.056 | < .0001 |
| Peripheral Artery Disease | 0.094 | 0.046 | 0.142 | 0.0001 |
| Stroke or TIA | 0.135 | 0.112 | 0.158 | < .0001 |
| 0.072 | 0.043 | 0.101 | < .0001 | |
| < .0001 | ||||
| Often | 0.009 | -0.009 | 0.026 | 0.324 |
| Sometimes | 0 | |||
| Rarely/Never | -0.031 | -0.044 | -0.018 | < .0001 |
| 0.0093 | ||||
| Africa | 0.004 | -0.024 | 0.032 | 0.77 |
| Bangladesh | 0.005 | -0.021 | 0.031 | 0.69 |
| Europe | -0.011 | -0.038 | 0.016 | 0.43 |
| India | 0.001 | -0.022 | 0.025 | 0.90 |
| Jamaica | 0.012 | -0.010 | 0.034 | 0.29 |
| Other | 0.048 | -0.081 | 0.177 | 0.47 |
| Other Asia | 0.055 | -0.022 | 0.131 | 0.16 |
| Pakistan | -0.016 | -0.039 | 0.008 | 0.19 |
| West Indies | 0 |
*Loge (number of conditions +1) #p value for overall effect from F test < .0001; ~p value for overall effect = 0.0093
Study characteristics of E-ECHOES compared to UK population norms [9,10]
| E-ECHOES | ||
|---|---|---|
| Study period | September 2006 to July 2009 | Last quarter 1993 |
| Population | SA and AC subjects from 20 practices in Birmingham, UK | Addresses in the UK to provide a sample representative of the general population with respect to age, gender and social class. |
| Sampling frame (n) | 10902 | 6080 addresses |
| Number of participants (response rate, %) | 5354 (49.1%) | 3395 (55.8%) |
| Inclusion criteria | SA or AC aged > 45 years. | Age ≥ 18 years |
| Exclusion criteria | Dementia or terminal illness | Individuals in institutions, hostels, homes for the elderly or bed and breakfast |
| EQ-5D data collection | Interview | Questionnaire (as part of an interview process) |